News

We are so proud to share that our partner Marcus Buggert was awarded the prestigious Anders Jahre award for Medical Research!! Marcus Buggert is an Assistant Professor at the Karolinska Institutet and he got the price for his studies on HIV and SARS-CoV-2 Cellular Mediated Immunity, which are used in the EuCARE project. Congratulations to Marcus Buggert and also […]

The protocol of the EuCARE-hospitalised cohort study was published on 16th of October by EuCARE partners of Workpackages 2, 3 and 5. This study, which is currently ongoing, follows up hospitalized adult patients with confirmed SARS-CoV-2 infection. The main aim of the study is to gather clinical and laboratory variables from around 35,000 patients. The

For the second consecutive time, the Institute of Hygiene and Tropical Medicine, Universidade NOVA de Lisboa, in Lisbon, Portugal, hosted the EuCARE Annual Scientific Board Meeting! The meeting occurred between the 23th and the 24th of October and consisted of two days filled with interesting face-to-face discussions, vivid knowledge sharing and fresh science! Many issues

The meeting ‘Joint Dialogue on Preparedness’,organized by EuCARE partners on the 24th October between 14:30 – 17:30, will join leading experts in this field!! It will take place in the Institute of Hygiene and Tropical Medicine, Universidade Nova de Lisboa, Portugal and online. Key opinion leaders will join for an interdisciplinary dialogue with short, provocative

Two weeks before our Annual meeting, organized by IBM partners to take place in TelAviv, Israel, the media bring us the news about the terrible inhuman terror attack on civilians in Israel. The EuCARE partners are devastated and deeply saddened with the violence and war in the region and hope for peace to come. Particularly

This new study, published yesterday, 3rd of October by the EuCARE partners from the Vilnius University Hospital Santaros Klinikos (VULSK), in the British Journal of Haematology, shows improved protection against Omicron infection and severe COVID-19 for those who received a third (booster) dose of mRNA vaccine. In this study, the final cohort included 912 patients

This year, once again, the EuCARE project was present on the European Researchers’ Night in two European cities: Lisbon and Rome! Last Friday and Saturday, 29th and 30th of September, EuCARE researchers were present in two venues Europe-wide to promote activities of science dissemination related to the EuCARE project. The action disseminated the work developed

The COVID-19 pandemic pushed education from schools to educational technologies at a pace and scale with no historical precedent. For hundreds of millions of students, schools closure lead to formal learning becoming fully dependent on technology. This new book published by Unesco “An ed-tech tragedy? Educational technologies and school closures in the time of COVID-19”

A new publication, published on 4th of September by the EuCARE partners Pontus Hedberg and Pontus Nauclér from Karoliska Institute, shows a reduced risk of acquiring Post-COVID Condition (PCC) after a primary infection with omicron variant when compared to older variants. In this report, there were 215,279 individuals in the omicron cohort, 52,182 in the

Portugal and Mexico are going to restart the “Lolli” testing in schools to complete the second period of testing. The EuCARE schools study was completed in Italy between November 2022 and June 2023. As planned, two periods of SARS-CoV-2 testing occurred with crossover of classes between control and intervention groups. In Portugal and Mexico, the